Results 271 to 280 of about 63,586 (320)

Comparison of hematoma block and dexmedetomidine for reduction of distal radius fractures in the emergency department: a prospective randomized controlled study. [PDF]

Ulus Travma Acil Cerrahi Derg
Vişneci EF, Acar D, Eravşar E, Kozanhan B, Demirci OL, Gül M.   +5 more
europepmc   +1 more source

Evaluating dexmedetomidine's opioid-sparing effect with ropivacaine in ultrasound-guided erector spinae block during mastectomy - A randomized clinical trial. [PDF]

Saudi J Anaesth
Barakat H, Al Nawwar R, Gholmieh L, Chahine C, Karake M, Assaf G, Al Jalbout Y.   +6 more
europepmc   +1 more source

Dexmedetomidine Alleviates Hippocampal Tissue Damage in Rapid Eye Movement Sleep-Deprived Rats by Activating BDNF/TrkB Signaling Pathway. [PDF]

Nat Sci Sleep
Zheng B, Li Y, Liu C.
europepmc   +1 more source

Effect of combined dexmedetomidine with ropivacaine in transversus thoracis plane block on surgical stress response during cardiopulmonary bypass surgery: a randomized controlled trial. [PDF]

Front Cardiovasc Med
Huang L, Chen Y, Xu X, Zeng F, Li C, Fu H.   +5 more
europepmc   +1 more source

Effect of intravenous dexmedetomidine on sensory block duration in spinal anesthesia for lower limb surgery: a randomized controlled trial. [PDF]

Braz J Anesthesiol
Chahal S, Bhalotra AR, Singh R, Dhiman S, Singh S.   +4 more
europepmc   +1 more source

Erratum: A randomized controlled clinical trial to investigate the efficacy and safety of dexmedetomidine in treating postoperative acute pain. [PDF]

Saudi J Anaesth
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose Associated 90-day Mortality: A Secondary Cohort Analysis of a Randomized Controlled Trial (SPICE-III).

American Journal of Respiratory and Critical Care Medicine, 2022
RATIONALE Sedation Practice in Intensive Care Evaluation (SPICE-III) trial reported significant heterogeneity in mortality with dexmedetomidine treatment. Supplemental propofol was commonly used to achieve desirable sedation. OBJECTIVES to quantify the
Y. Shehabi, A. Serpa Neto, R. Bellomo, B. Howe, Y. Arabi, M. Bailey, F. Bass, Suhaini Bin Kadiman, C. McArthur, M. Reade, I. Seppelt, J. Takala, M. Wise, S. Webb   +13 more
semanticscholar   +1 more source

Dexmedetomidine for dyspnoea

BMJ Supportive & Palliative Care, 2020
Dexmedetomidine is a selective α2-adrenoreceptor agonist with a broad range of effects, including easily controllable sedation, analgesia and anxiolysis. Because of these favorable features, it has replaced traditional sedatives, such as benzodiazepines, and is becoming the first-line sedative for the patients in intensive care units.
Akiko Mano, Tomohiro Murata, Kazuma Date, Mitsuhiro Kawata, Miyuki Sato, Norie Yamashita, Kimie Iino, Shunei Kyo, Eiichi Saito   +8 more
openaire   +3 more sources

The potential role of dexmedetomidine on neuroprotection and its possible mechanisms: Evidence from in vitro and in vivo studies

European Journal of Neuroscience, 2021
Neurological disorders following brain injuries and neurodegeneration are on the rise worldwide and cause disability and suffering in patients. It is crucial to explore novel neuroprotectants.
K. Unchiti, P. Leurcharusmee, A. Samerchua, Tanyong Pipanmekaporn, N. Chattipakorn, S. Chattipakorn   +5 more
semanticscholar   +1 more source